Intermittent versus continuous first-line treatment for HER2-negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG)
Claessens, Anouk K. M., Bos, Monique E. M. M., Lopez-Yurda, Marta, Bouma, Jeanette M., Rademaker-Lakhai, Jeany M., Honkoop, Aafke H., de Graaf, Hiltje, van Druten, Edith, van Warmerdam, Laurence J. C.Language:
english
Journal:
Breast Cancer Research and Treatment
DOI:
10.1007/s10549-018-4906-8
Date:
August, 2018
File:
PDF, 985 KB
english, 2018